Evidence map›Paper›PMID 33434146›Full record

ReviewJournal of molecular endocrinology2021

Hepatic metabolic regulation by nuclear factor E4BP4.

Zifeng Zhao, Lei Yin, Feihua Wu, Xin Tong

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of molecular endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. A new border for circadian rhythm gene NFIL3 in diverse fields of cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Zifeng ZhaoDepartment of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu Province, China.
Lei YinDepartment of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Feihua WuDepartment of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu Province, China.
Xin TongDepartment of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
China Pharmaceutical University · CNUniversity of Michigan–Ann Arbor · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kanakadurga Singer · 2010 to 2026
$20.3M
Significance and mechanisms of hepatic ChREBPα induction via post-translational modifications in diet-induced NASHR01DK099593 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YIN, LEI · 2014 to 2025
$4.5M
Mechanisms by which adipocytes adapt to cool environmental temperaturesR01DK121759 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MACDOUGALD, ORMOND A · 2020 to 2024
$2.0M
Role and Mechanisms of E4BP4 over-activation in diet-induced fatty liver diseaseR01DK121170 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TONG, XIN · 2019 to 2022
$1.6M
Biology of nuclear receptor Rev-erb alpha in circadian rhythm and metabolismR00DK077449 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YIN, LEI · 2009 to 2011
$724k
Biology of nuclear receptor rev-erb alpha in circadian rhythm and metabolismK99DK077449 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI YIN, LEI · 2007 to 2009
$146k
NIDDK NIH HHS K99 DK077449NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIDDK NIH HHS R00 DK077449NIDDK NIH HHS R01 DK099593NIDDK NIH HHS R01 DK121170NIDDK NIH HHS R01 DK121759
6 · The paper itself

Abstract

Discovered as a b-ZIP transcription repressor 30 years ago, E4 promoter-binding protein 4 (E4BP4) has been shown to play critical roles in immunity, circadian rhythms, and cancer progression. Recent research has highlighted E4BP4 as a novel regulator of metabolisms in various tissues. In this review, we focus on the function and mechanisms of hepatic E4BP4 in regulating lipid and glucose homeostasis, bile metabolism, as well as xenobiotic metabolism. Finally, E4BP4-specific targets will be discussed for the prevention and treatment of metabolic disorders.

Indexed as

Energy MetabolismAnimalsBasic-Leucine Zipper Transcription FactorsBile Acids and SaltsCell NucleusGlucoseHumansInsulinLipid MetabolismLiverBasic-Leucine Zipper Transcription FactorsBile Acids and SaltsGlucoseInsulinNFIL3 protein, humanE4BP4glucoseinsulinlipidmetabolism

Identifiers

PMID33434146
PMCPMC7808567
OpenAlexW3095852947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.